Related Experiment Video
Updated: Mar 19, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Pancreatic Cancer: Planning Ahead for Metastatic Spread
Ingunn M Stromnes1, Philip D Greenberg2
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Abstract:
Metastasis and therapy resistance are cardinal features of pancreatic ductal adenocarcinoma, a commonly lethal malignancy. In this issue of Cancer Cell, Steele et al. show that CXCR2 expression and neutrophils are required for metastasis. In mice treated with advanced disease, inhibiting both CXCR2 and PD1 cooperatively but not individually prolongs survival.
Insights
Pancreatic cancer metastasis relies on CXCR2 and neutrophils. Combining CXCR2 and PD1 inhibition in mice with advanced disease significantly improved survival, unlike individual treatments.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy characterized by metastasis and therapy resistance.
- Understanding the mechanisms driving PDAC progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of CXCR2 and neutrophils in pancreatic cancer metastasis.
- To evaluate the therapeutic potential of inhibiting CXCR2 and PD1 in advanced PDAC.
Main Methods:
- Utilized mouse models of advanced pancreatic ductal adenocarcinoma.
- Assessed the impact of CXCR2 and PD1 inhibition on metastasis and survival.
- Examined the cooperative and individual effects of these targeted therapies.
Main Results:
- CXCR2 expression and neutrophils were identified as critical drivers of pancreatic cancer metastasis.
- Inhibition of both CXCR2 and PD1 synergistically prolonged survival in mice with advanced disease.
- Individual inhibition of CXCR2 or PD1 did not significantly improve survival outcomes.
Conclusions:
- CXCR2 and neutrophils are essential for pancreatic cancer metastasis.
- Combined CXCR2 and PD1 blockade represents a promising therapeutic strategy for advanced pancreatic ductal adenocarcinoma.
More Related Videos
13:56Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
12:07Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
Published on: November 18, 2022
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Chronic Pancreatitis II: Collaborative Care
Assessment: